Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells

References

• ArndtCACristWMCommon musculoskeletal tumors of childhood and adolescenceN Engl J Med1999341534235210423470
   PubMed Web of Science ®Google Scholar
• BielackSSMarinaNFerrariSOsteosarcoma: the same old drugs or more?J Clin Oncol2008261831023103 author reply 3104–310518565904
   PubMed Web of Science ®Google Scholar
• GillJAhluwaliaMKGellerDGorlickRNew targets and approaches in osteosarcomaPharmacol Ther20131371899922983152
   PubMed Web of Science ®Google Scholar
• GellerDSGorlickROsteosarcoma: a review of diagnosis, management, and treatment strategiesClin Adv Hematol Oncol201081070571821317869
   PubMedGoogle Scholar
• ChouAJGellerDSGorlickRTherapy for osteosarcoma: where do we go from here?Paediatr Drugs200810531532718754698
   PubMedGoogle Scholar
• ChouAJGorlickRChemotherapy resistance in osteosarcoma: current challenges and future directionsExpert Rev Anticancer Ther2006671075108516831079
   PubMed Web of Science ®Google Scholar
• SubramanianSLuiWOLeeCHMicroRNA expression signature of human sarcomasOncogene200827142015202617922033
   PubMed Web of Science ®Google Scholar
• JonesKBSalahZDel MareSmiRNA signatures associate with pathogenesis and progression of osteosarcomaCancer Res20127271865187722350417
   PubMed Web of Science ®Google Scholar
• HeneghanHMMillerNKerinMJMiRNAs as biomarkers and therapeutic targets in cancerCurr Opin Pharmacol201010554355020541466
   PubMed Web of Science ®Google Scholar
• KobayashiEHornicekFJDuanZMicroRNA Involvement in OsteosarcomaSarcoma2012201235973922550419
   PubMedGoogle Scholar
• DuanZChoyEHarmonDMicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migrationMol Cancer Ther20111081337134521666078
   PubMed Web of Science ®Google Scholar
• DuanZChoyENielsenGPDifferential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expressionJ Orthop Res201028674675220041488
   PubMed Web of Science ®Google Scholar
• FornariFMilazzoMChiecoPMiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cellsCancer Res201070125184519320501828
   PubMed Web of Science ®Google Scholar
• HenryJCParkJKJiangJmiR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell linesBiochem Biophys Res Commun2010403112012521055388
   PubMed Web of Science ®Google Scholar
• WuDHuangHJHeCNWangKYMicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR)Int J Gynecol Cancer20132371191119723851675
   PubMed Web of Science ®Google Scholar
• YanaiharaNCaplenNBowmanEUnique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell20069318919816530703
   PubMed Web of Science ®Google Scholar
• DongQMengPWangTMicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2PloS One201054e1014720418948
   PubMed Web of Science ®Google Scholar
• JakymiwAPatelRSDemingNOverexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cellsGenes Chromosomes Cancer201049654955920232482
   PubMed Web of Science ®Google Scholar
• ChenYJacamoRKonoplevaMGarzonRCroceCAndreeffMCXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemiaJ Clin Invest201312362395240723676502
   PubMed Web of Science ®Google Scholar
• YuCCChenYWChiouGYMicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablationOral Oncol201147320221021292542
   PubMed Web of Science ®Google Scholar
• KimSJShinJYLeeKDMicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7Breast Cancer Res2012141R1422251626
   PubMed Web of Science ®Google Scholar
• WangMHuYAmatangeloMDStearnsMERole of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancerMol Cancer Res201191365021148031
   PubMed Web of Science ®Google Scholar
• AkaoYNakagawaYNaoeTlet-7 microRNA functions as a potential growth suppressor in human colon cancer cellsBiol Pharm Bull200629590390616651716
   PubMed Web of Science ®Google Scholar
• BravoVRoseroSRicordiCPastoriRLInstability of miRNA and cDNAs derivatives in RNA preparationsBiochem Biophys Res Commun200735341052105517204243
   PubMed Web of Science ®Google Scholar
• ShuklaGCHaqueFTorYA boost for the emerging field of RNA nanotechnologyACS Nano2011553405341821604810
   PubMed Web of Science ®Google Scholar
• ChenYZhuXZhangXLiuBHuangLNanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapyMol Ther20101891650165620606648
   PubMed Web of Science ®Google Scholar
• CrewETesselMARahmanSMicroRNA conjugated gold nanoparticles and cell transfectionAnal Chem2012841262922148593
   PubMed Web of Science ®Google Scholar
• MuthiahMParkIKChoCSNanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeuticsExpert Opin Drug Deliv20131091259127323826971
   PubMed Web of Science ®Google Scholar
• KesharwaniPGajbhiyeVJainNKA review of nanocarriers for the delivery of small interfering RNABiomaterials201233297138715022796160
   PubMed Web of Science ®Google Scholar
• ShenHSunTFerrariMNanovector delivery of siRNA for cancer therapyCancer Gene Ther201219636737322555511
   PubMed Web of Science ®Google Scholar
• SusaMIyerAKRyuKDoxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcomaBMC Cancer2009939919917123
   PubMed Web of Science ®Google Scholar
• SusaMIyerAKRyuKInhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcomaPloS One201055e1076420520719
   PubMed Web of Science ®Google Scholar
• KobayashiEIyerAKHornicekFJAmijiMMDuanZLipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot studyClin Orthop Relat Res20B;4713915925
   Web of Science ®Google Scholar
• MartwisetSKohAEChenWNonfouling characteristics of dextran-containing surfacesLangmuir200622198192819616952261
   PubMed Web of Science ®Google Scholar
• Cubillos-RuizJRSempereLFConejo-GarciaJRGood things come in small packages: Therapeutic anti-tumor immunity induced by microRNA nanoparticlesOncoimmunology20121696897023162774
   PubMed Web of Science ®Google Scholar
• CroceCMCauses and consequences of microRNA dysregulation in cancerNat Rev Genet2009101070471419763153
   PubMed Web of Science ®Google Scholar
• SunKWangJZhangJHuaMLiuCChenTDextran-g-PEI nanoparticles as a carrier for co-delivery of adriamycin and plasmid into osteosarcoma cellsInt J Biol Macromol201149217318021539858
   PubMed Web of Science ®Google Scholar
• AbediniFHosseinkhaniHIsmailMCationized dextran nanoparticle-encapsulated CXCR4-siRNA enhanced correlation between CXCR4 expression and serum alkaline phosphatase in a mouse model of colorectal cancerInt J Nanomedicine201274159416822888250
   PubMed Web of Science ®Google Scholar
• ChoHJChongSChungSJShimCKKimDDPoly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatmentPharm Res20122941007101922169985
   PubMed Web of Science ®Google Scholar
• KimJSOhMHParkJYParkTGNamYSProtein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNABiomaterials20133492370237923294546
   PubMed Web of Science ®Google Scholar